Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Fat LossMuscle BuildingInjury HealingAnti-AgingCognitive EnhancementSleep OptimizationImmune SupportGut HealingSkin RejuvenationSexual Health
Peptides
Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PNC-27
Cancer Research
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 32
Back to Home

Immune Protocol

Lactoferricin BComplete Dosing & Administration Guide

A 25-amino-acid antimicrobial peptide fragment derived from bovine lactoferrin by pepsin cleavage, featuring a twisted antiparallel beta-sheet structure with broad-spectrum bactericidal activity, anti-biofilm properties, and emerging anticancer potential through selective membrane disruption mediated by the critical RRWQWR motif

Dose Range

1-10mg

Frequency

Multiple times daily

Route

Oral (research — resistant to gastric digestion)

Cycle Length

4-6 weeks

Dosing

How much
do I take?

Starting Dose

1-2 mg orally or 2-5 µg/mL in research solution

Frequency

Once daily

Duration

3-5 days initial evaluation

Begin with low-dose oral administration or low-concentration in vitro protocols. Lactoferricin B shows partial resistance to further gastric degradation (its structure is relatively stable once formed by pepsin cleavage). For topical research, use in appropriate buffer at pH 6-7. In vitro MIC testing uses 0.3-150 µg/mL range depending on organism. This is a research compound — use under supervised protocols.

Standard Dose

5 mg orally or 10-50 µg/mL in research solution

Frequency

Once to twice daily

Duration

7-10 days

Standard research dose range. Oral lactoferricin B can be derived from intact lactoferrin supplementation (250-500 mg lactoferrin generates lactoferricin during digestion) or administered as synthetic peptide. In vitro and ex vivo studies use concentrations up to 50 µg/mL for antimicrobial and anti-biofilm evaluation. Prepare in low-salt buffer to maintain activity. Combined with probiotics for gut antimicrobial research.

Advanced Dose

10 mg or 50-100 µg/mL in research solution

Frequency

Once to twice daily

Duration

10-14 days

Higher concentrations used for anticancer research, established biofilm eradication, and immunomodulation studies. Tetrameric lactoferricin constructs show enhanced anticancer activity (MCF-7 IC50 22 µM). Monitor for hemolytic activity at concentrations approaching 100 µg/mL — this is the primary dose-limiting toxicity. Low-salt conditions required for optimal activity.

Timing

Best time to take

Take Lactoferricin B at the same time each day for consistent blood levels. Morning dosing with breakfast is often preferred, but follow your healthcare provider's specific instructions.

With food?

Lactoferricin B can typically be taken with or without food. Taking it with a light meal may help reduce any GI discomfort. Avoid taking with grapefruit juice or high-fat meals unless specifically directed.

If stacking

Lactoferricin B should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.

Adjusting Your Dose

Increase if

  • +You've tolerated the current dose for the recommended period without significant side effects
  • +Therapeutic goals haven't been met at the current dose level
  • +Your healthcare provider recommends dose escalation based on your response
  • +Lab work or clinical assessments support a higher dose

Decrease if

  • -Side effects are bothersome or impacting daily life despite management strategies
  • -You experience any signs of an adverse reaction
  • -Lab results indicate the need for dose reduction
  • -Your healthcare provider recommends a lower dose based on your response

Signs of right dose

  • Therapeutic goals being met with minimal side effects
  • Stable and consistent response to treatment
  • Lab values or clinical markers trending in the right direction
  • Good tolerance with manageable or absent side effects

Dosing Calculator

Calculate Your Exact Dose

1
2
3
4

Step 1: Peptide Weight

Find the weight printed on your peptide vial label

Look here!

The weight is on the label

Peptide vial
5mg

Select Weight

mg

Look for a number followed by 'mg' on the vial label (e.g., 5mg, 10mg)

Administration

How do I
use it?

Reconstitution

What you need

  • Lactoferricin B in its prescribed form
  • Clean, dry storage container
  • Measuring device if applicable (oral syringe, measuring cup)
  • Calendar or reminder app for dosing schedule

Example

Lactoferricin B comes in pre-measured doses or forms. Follow the exact dosing instructions on your prescription label. No reconstitution or mixing is typically required for this formulation.

Use Lactoferricin B exactly as prescribed. Each unit contains the labeled amount. Your healthcare provider will determine the appropriate dose based on your individual needs and response.

Injection

Route

Lactoferricin B is administered Oral (research — resistant to gastric digestion)—no injection required

Best sites

  • Not applicable—this is not an injectable formulation

Technique

  • 1.Follow the specific administration instructions for your Lactoferricin B formulation
  • 2.Take or apply as directed by your healthcare provider
  • 3.Store properly between uses according to package instructions

Storage

Before reconstitution

Store Lactoferricin B in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.

After reconstitution

Once reconstituted, Lactoferricin B should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.

Signs of degradation

  • Solution appears cloudy, discolored, or contains visible particles (should be clear)
  • Product has been exposed to temperatures outside the recommended storage range
  • Product has been frozen (unless specifically designed for freeze-thaw stability)
  • Expiration date has passed or reconstituted solution has exceeded its use-by date
  • Unusual odor, color change, or visible contamination

Sample Daily Schedule

As prescribed (twice daily)

As prescribed by your healthcare provider injection

Site: Oral (research — resistant to gastric digestion)—rotate sites if applicable

Maintain a consistent schedule for optimal results with Lactoferricin B. Set reminders if needed. If you miss a dose, follow your healthcare provider's instructions—do not double up on doses to compensate.

Safety

Is it
safe?

Safety Profile

Lactoferricin B is a 25-amino acid peptide fragment of human lactoferrin with a well-documented natural history—derived from a dietary protein that humans consume in breast milk and dairy products. Preclinical studies show excellent tolerability with no hepatotoxicity, nephrotoxicity, or genotoxicity in animal models even at supraphysiological doses. The antimicrobial and antifungal mechanism (iron sequestration and membrane disruption) appears selective for pathogenic microorganisms with minimal effect on commensal bacteria at therapeutic concentrations.

Lactoferricin B safety is supported by extensive in vitro antimicrobial efficacy data and preclinical pharmacology studies published in Peptides and Antimicrobial Agents and Chemotherapy. Human clinical data remain limited to small feasibility studies and oral bioavailability investigations. Oral bioavailability is low due to peptidase degradation, limiting systemic exposure. Topical and intranasal applications show localized efficacy in pilot studies without documented systemic adverse events.

Common Side Effects

Experienced by some users

Mild GI discomfort

Bloating, mild nausea, or slight abdominal discomfort with oral research doses. Related to antimicrobial modulation of the gut microbiome and the intensely cationic nature of the peptide.

Management: Take with food. Start with lower doses and titrate up. Usually resolves within 2-3 days as the GI tract adjusts.

Bitter taste

Characteristic bitter taste of cationic peptides with high arginine content when taken orally without capsule encapsulation.

Management: Use enteric-coated capsules or mix with flavored vehicle. Alternatively, obtain lactoferricin naturally through lactoferrin supplementation.

Local irritation (topical use)

Mild redness, warmth, or stinging at the topical application site related to the peptide's interaction with skin tissue.

Management: Use appropriate buffer and formulation vehicle. Reduce concentration if irritation persists. Self-limiting.

Mild flatulence

Increased gas production from antimicrobial effects on gut microbiota, particularly in the first few days of oral administration.

Management: Transient — resolves as gut microbiome adjusts. Take with meals. Consider probiotic co-administration.

Less Common

  • Allergic reaction in milk-sensitive individuals

These typically resolve with continued use or dose adjustment.

Stop and Seek Help If

  • ×Severe or worsening side effects that don't improve with dose adjustment or supportive care
  • ×Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
  • ×Your healthcare provider recommends discontinuation based on your clinical response
  • ×Development of any new medical condition that may be contraindicated with Lactoferricin B
  • ×Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
  • ×Abnormal lab results or clinical markers that suggest adverse effects

Lactoferricin B should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.

Interactions

With other peptides

  • May be used together under medical guidance.
  • May be used together under medical guidance.
  • May be used together under medical guidance.

With medications

  • !High-concentration NaCl solutions (>150 mM) — salt sensitivity reduces lactoferricin's electrostatic membrane binding and antimicrobial potency significantly - Use with caution—discuss with your healthcare provider.
  • !Iron supplements at the same time — iron may compete for residual binding sites on the lactoferricin fragment and alter peptide activity - Use with caution—discuss with your healthcare provider.
  • !Anionic polysaccharides in excess (carrageenan, xanthan gum) — may electrostatically sequester the cationic lactoferricin peptide - Use with caution—discuss with your healthcare provider.

With supplements

  • Multivitamins - Generally safe to take alongside Lactoferricin B. Space doses apart if taking oral formulations to ensure optimal absorption.
  • Electrolyte supplements - Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.

Want the Full Picture?

View the complete Lactoferricin B research profile including mechanism of action, clinical studies, effectiveness timeline, and FAQ.

View Full Lactoferricin B Profile

Medical Disclaimer

Lactoferricin B is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare provider before starting any new supplement or treatment protocol.

Last updated: 2/8/2026